Jalra-M 50mg/1000mg Tablet 15s

Jalra-M 50mg/1000mg Tablet 15s is an effectively manage diabetes by harnessing the unique properties of each component. Metformin works to reduce sugar production in the liver, slow down sugar absorption from the intestines, and enhance the body's responsiveness to insulin. Meanwhile, Vildagliptin, a DPP4 inhibitor, increases insulin release from the pancreas and reduces hormones that elevate blood sugar, providing comprehensive control over fasting and post meal sugar levels when used together.

The combination of Metformin and Vildagliptin targets multiple aspects of glucose regulation, offering a comprehensive approach to diabetes care.

Metformin reduces liver sugar production, slows sugar absorption, and enhances insulin sensitivity. Vildagliptin boosts insulin release and reduces blood sugar elevating hormones, achieving better control over fasting and post meal sugar levels when used in tandem.

Follow your doctor's guidance on dose and duration. Strict adherence to the prescribed dose and treatment duration is essential for effectiveness.

Common side effects may include nausea, vomiting, diarrhea, flatulence, low blood sugar, and upset stomach. These effects are generally mild and temporary, but if persistent, consult your healthcare provider for guidance.

Monitoring blood glucose regularly, assessing kidney function, watching for signs of lactic acidosis (muscle pain, respiratory distress), and exercising caution in cases of liver impairment are crucial precautions Inform your healthcare provider of any unusual symptoms promptly.

In case you forget to take a dose of medication take it promptly. However, if the next dose is near, skip the missed one to avoid doubling up. Doubling the dose is not recommended for safe and effective use. Adhere strictly to your regular schedule and consult your healthcare provider with any concerns for optimal outcomes.